Completed PHASE2 INTERVENTIONAL 1-arm NCT00580970

Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury

A Phase II Study to Prevent Radiation-Induced Rectal Injury With Lovastatin

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center

Interventions lovastatin

Updated 6 times since 2017 Last updated: Sep 28, 2016 Started: Apr 30, 2007 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00580970, this PHASE2 trial focuses on Prostate Cancer and remains completed. Sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hunter Holmes Mcguire Veteran Affairs Medical Center
Virginia Commonwealth University

Data source: Virginia Commonwealth University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Richmond, United States